Followers | 248 |
Posts | 10,019 |
Boards Moderated | 1 |
Alias Born | 07/25/2008 |
Twitter Profile: | Temporarily Unavailable |
Follow on Twitter: | Follow @ Temporarily Unavailable |
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Time to start loading again
locked and loaded back to 10 bucks
5300 looks a lot more likely #ES
Love the updates to the site!!!
Beautiful chart love
Haven't been posting for a few months it seems now... still here still sitting on the bid collecting what few shares anyone is willing to let go of... when the fireworks start. And they will. I know all the ones to truly congratulate for having balls of steel throughout the past 2 years. NTRR NICKEL INCOMING
More revenue... just a matter of time $NTRR
12 bucks coming
$ARBK BITCOIN MINING EARNINGS
$NTRR DONT MISS THE WAVE. 500K $ FRIDAY VOLUME. MARIJUANA TOP CBD STOCK ON THE OTC
Strong support for the creamiest stock on the otc $NTRR NICKEL INBOUND
Wow 0007, and I didn't get one share today... maybe get lucky tomorrow $NTRR
Little girls losing their shares daily. $NTRR MOONSHOT 2022
Lfg! $NTRR
Lfg! $ROOT
Lfg! $CLOV
Nickel is going to come quick. $NTRR
Soon patience will be rewarded 500 fold $NTRR
Load up the coffers. $NTRR NICKEL INBOUND
Loading up like crazy this week... this month might be the last time for subs ... $NTRR NICKEL INBOUND
Added in a big way yesterday... $NTRR nickel inbound
Keep adding and smiling. Nickel inbound $NTRR
Will become a national brand and we will see massive numbers... Texas on lock with vivis products... $NTRR first stop is a nickel
Gobble gobble $NTRR
It's coming $NTRR
Nickel inbound $NTRR
Get ready for an explosion
Alot bigger than Moderna
Those talking about dilution, 50mm shares is nothing. My group owns so much more than that. Pathetic attempt at keeping this gem down... patience will pay off huge $NTRR
Love the placement and price point on retail, under number 1 selling products
$BIOL - EARNINGS BEAT
2021 Second Quarter Operating Highlights (all comparisons are on a year-over-year basis unless specified otherwise):
Net revenue grew 211% to $9.1 million:
Over 70% of U.S. laser sales came from new customers, continuing a positive trend
Over 35% of U.S. Waterlase sales came from dental specialists
Net revenue was 6% higher than the pre-pandemic revenues during the second quarter of 2019
Laser system sales increased 424%
Consumables and other revenue increased 173%
U.S. and international revenue increased 167% and 340%, respectively, as more dental practices were operating during the 2021 second quarter compared to the year-ago second quarter due to the COVID-19 pandemic
Gross margin was 44%, up 1,200 basis points, due to the higher year-over-year revenue, favorable revenue mix and higher average selling prices for products sold during the quarter
Net loss was $702,000 or $0.00 per share, compared to a net loss of $4.7 million or $0.12 per share a year ago
Maintained strong balance sheet, as cash and cash equivalents totaled $37.1 million at quarter end
$BIOL - EARNINGS BEAT
2021 Second Quarter Operating Highlights (all comparisons are on a year-over-year basis unless specified otherwise):
Net revenue grew 211% to $9.1 million:
Over 70% of U.S. laser sales came from new customers, continuing a positive trend
Over 35% of U.S. Waterlase sales came from dental specialists
Net revenue was 6% higher than the pre-pandemic revenues during the second quarter of 2019
Laser system sales increased 424%
Consumables and other revenue increased 173%
U.S. and international revenue increased 167% and 340%, respectively, as more dental practices were operating during the 2021 second quarter compared to the year-ago second quarter due to the COVID-19 pandemic
Gross margin was 44%, up 1,200 basis points, due to the higher year-over-year revenue, favorable revenue mix and higher average selling prices for products sold during the quarter
Net loss was $702,000 or $0.00 per share, compared to a net loss of $4.7 million or $0.12 per share a year ago
Maintained strong balance sheet, as cash and cash equivalents totaled $37.1 million at quarter end
$BIOL EPS beat, guidance raised, large short percentage of float... weekly chart setup is ready to launch into dollar territory
$BIOL EPS BEAT, WEEKLY CHART ABOUT TO TRIPLE
$BIOL WEEKLY SETUP ready for a major move